Seminars in Nuclear Medicine
Volume 31, Issue 4 , Pages 286-295 , October 2001

Radiopharmaceuticals to image infection and inflammation

References 

  1. Lavender JP, Lowe J, Barker JR, et al. Gallium 67 citrate scanning in neoplastic and inflammatory lesions. Br J Radiol. 1971;44:361–366
  2. Ito Y, Okuyama S, Awano T, et al. Diagnostic evaluation of Ga-67 scanning of lung cancer and other diseases. Radiology. 1971;101:355–362
  3. Tsan MF. Mechanism of gallium-67 accumulation in inflammatory lesions. J Nucl Med. 1985;26:88–92
  4. Weiner R. The role of transferrin and other receptors in the mechanism of 67Ga localization. Int J Rad Appl Instrum B. 1990;17:141–149
  5. Palestro CJ. The current role of gallium imaging in infection. Semin Nucl Med. 1994;24:128–141
  6. Perkins PJ. Early gallium-67 abdominal imaging: Pitfalls due to bowel activity. AJR Am J Roentgenol. 1981;136:1016–1017
  7. Bekerman C, Hoffer PB, Bitran JD. The role of gallium-67 in the clinical evaluation of cancer. Semin Nucl Med. 1984;14:296–323
  8. Seabold JE, Nepola JV, Conrad GR, et al. Detection of osteomyelitis at fracture nonunion sites: Comparison of two scintigraphic methods. AJR Am J Roentgenol. 1989;152:1021–1027
  9. McAfee JG, Thakur ML. Survey of radioactive agents for the in vitro labeling of phagocytic leucocytes. I. Soluble agents. II. Particles. J Nucl Med. 1976;17:480–492
  10. Thakur ML, Lavender JP, Arnot RN, et al. Indium-111-labeled autologous leukocytes in man. J Nucl Med. 1977;18:1014–1021
  11. Thakur ML, Coleman RE, Welch MJ. Indium-111-labeled leukocytes for the localization of abscesses: Preparation, analysis, tissue distribution, and comparison with gallium-67 citrate in dogs. J Lab Clin Med. 1977;89:217–228
  12. Peters AM, Danpure HJ, Osman S, et al. Preliminary clinical experience with 99mTc-hexamethyl propylene-amineoxime for labeling leucocytes and imaging infection. Lancet. 1986;2(8513):945–949
  13. Peters AM. The utility of [99mTc]HMPAO-leukocytes for imaging infection. Semin Nucl Med. 1994;24:110–127
  14. Datz FL. Indium-111-labeled leukocytes for the detection of infection: Current status. Semin Nucl Med. 1994;24:92–109
  15. Datz FL, Thorne DA. Effect of chronicity of infection on the sensitivity of the In-111-labeled leukocyte scan. AJR Am J Roentgenol. 1986;147:809–812
  16. Lange JMA, Boucher CAB, Hollak CEM, et al. Failure of zidovudine prophylaxis after accidental exposure to HIV-1. N Eng J Med. 1990;323:915–916
  17. Becker W, Saptogino A, Wolf F. The single late Tc-99m granulocyte antibody scan in inflammatory diseases. Nucl Med Commun. 1992;13:186–192
  18. Hasler PH, Novak-Hofer I, Blauenstein P, et al. The in vivo binding behaviour of an I-123 labelled anti-granulocytes antibody (Granuloszint). Prog Clin Biol Res. 1990;355:299–309
  19. Becker W, Palestro CJ, Winship J, et al. Rapid imaging of infections with a monoclonal antibody fragment (Leukoscan). Clin Orthop. 1996;329:263–272
  20. Barron B, Hanna C, Passalaqua AM, et al. Rapid diagnostic imaging of acute, nonclassic appendicitis by leukoscintigraphy with sulesomab, a technetium-99m-labeled antigranulocyte antibody Fab' fragment. Surgery. 1999;125:288–296
  21. Harwood SJ, Valdivia S, Hung GL, et al. Use of Sulesomab, a radiolabeled antibody fragment, to detect osteomyelitis in diabetic patients with foot ulcers by leukoscintigraphy. Clin Infect Dis. 1999;28:1200–1205
  22. Thakur ML, Marcus CS, Henneman P, et al. Imaging inflammatory diseases with neutrophil-specific technetium-99m-labeled monoclonal antibody anti-SSEA-1. J Nucl Med. 1996;37:1789–1795
  23. Kipper SL, Rypins EB, Evans DG, et al. Neutrophil-specific 99mTc-labeled anti-CD15 monoclonal antibody imaging for diagnosis of equivocal appendicitis. J Nucl Med. 2000;41:449–455
  24. Becker W, Borst U, Fischbach W, et al. Kinetic data of in vivo labelled granulocytes in humans with a murine Tc-99m-labelled monoclonal antibody. Eur J Nucl Med. 1989;15:361–366
  25. Mozley PD, Thakur ML, Alavi A, et al. Effects of a 99mTc-labeled murine immunoglobulin M antibody to CD15 antigens on human granulocyte membranes in healthy volunteers. J Nucl Med. 1999;40:2107–2114
  26. Becker W, Goldenberg DM, Wolf F. The use of monoclonal antibodies and antibody fragments in the imaging of infectious lesions. Semin Nucl Med. 1994;24:142–153
  27. Corstens FH, Oyen WJ, Becker WS. Radioimmunoconjugates in the detection of infection and inflammation. Semin Nucl Med. 1993;23:148–164
  28. Papos M, Nagy F, Narai G, et al. Anti-granulocyte immunoscintigraphy and [99mTc]hexamethylpropyleneamine-oxime-labeled leukocyte scintigraphy in inflammatory bowel disease. Dig Dis Sci. 1996;41:412–420
  29. Becker W, Bair J, Behr T, et al. Detection of soft-tissue infections and osteomyelitis using a technetium-99m-labelled antigranulocyte monoclonal antibody fragment. J Nucl Med. 1994;35:1436–1443
  30. Sakahara H, Reynolds JC, Carrasquillo JA, et al. In vitro complex formation and biodistribution of mouse antitumor monoclonal antibody in cancer patients. J Nucl Med. 1989;30:1311–1317
  31. Mozley PD, Stubbs JB, Dresel SH, et al. Radiation dosimetry of a 99mTc-labeled IgM murine antibody to CD15 antigens on human granulocytes. J Nucl Med. 1999;40:625–630
  32. Rubin RH, Young LS, Hansen WP, et al. Specific and nonspecific imaging of localized Fisher immunotype 1 Pseudomonas aeruginosa infection with radiolabeled monoclonal antibody. J Nucl Med. 1988;29:651–656
  33. Fischman AJ, Rubin RH, White JA, et al. Locali-zation of Fc and Fab fragments of nonspecific polyclonal IgG at focal sites of inflammation. J Nucl Med. 1990;31:1199–1205
  34. Fischman AJ, Fucello AJ, Pellegrino-Gensey JL, et al. Effect of carbohydrate modification on the localization of human polyclonal IgG at focal sites of bacterial infection. J Nucl Med. 1992;33:1378–1382
  35. Morrel EM, Tompkins RG, Fischman AJ, et al. Imaging infections with antibodies. A quantitative autoradiographic analysis. J Immunol Meth. 1990;130:39–48
  36. Oyen WJG, Claessens RAMJ, van der Meer JWM, et al. Indium-111-labeled human nonspecific immunoglobulin G: A new radiopharmaceutical for imaging infectious and inflammatory foci. Clin Infect Dis. 1992;14:1110–1118
  37. Nijhof MW, Oyen WJ, van Kampen A, et al. Evaluation of infections of the locomotor system with indium-111-labeled human IgG scintigraphy. J Nucl Med. 1997;38:1300–1305
  38. Buscombe JR, Oyen WJG, Grant A, et al. Indium-111-labeled human polyclonal immunoglobulin: Identifying focal infection in patients positive for human immunodeficiency virus (HIV). J Nucl Med. 1993;34:1621–1625
  39. Mairal L, Lima PD, Martin Comin J, et al. Simultaneous administration of 111In-human immunoglobulin and 99mTc-HMPAO labelled leukocytes in inflammatory bowel disease. Eur J Nucl Med. 1995;22:664–670
  40. Dams ETM, Oyen WJG, Boerman OC, et al. Technetium-99m labeled to human immunoglobulin G through the nicotinyl hydrazine derivative: A clinical study. J Nucl Med. 1998;39:119–124
  41. Keelan ET, Harrison AA, Chapman PT, et al. Imaging vascular endothelial activation: An approach using radiolabeled monoclonal antibodies against the endothelial cell adhesion molecule E-selectin. J Nucl Med. 1994;35:276–281
  42. Jamar F, Chapman PY, Harrison AA, et al. Inflammatory arthritis: Imaging of endothelial cell activation with an In-111-labeled F(ab')2 fragment of anti-E-selectin monoclonal antibody. Radiology. 1995;194:843–850
  43. Bhatti M, Chapman P, Jamar F, et al. Immunolocalization of active inflammatory bowel disease (IBD) using a monoclonal antibody against E-selectin. J Nucl Med. 1996;37(suppl 5):114P
  44. Chapman PT, Jamar F, Keelan ET, et al. Use of a radiolabeled monoclonal antibody against E-selectin for imaging of endothelial activation in rheumatoid arthritis. Arthritis Rheum. 1996;39:1371–1375
  45. Jamar F, Chapman PT, Manicourt DH, et al. A comparison between 111In-anti-E-selectin mAb and 99mTc-labelled human non-specific immunoglobulin in radionuclide imaging of rheumatoid arthritis. Br J Radiol. 1997;70:473–481
  46. Boerman OC, Storm G, Oyen WJG, et al. Sterically stabilized liposomes labeled with 111In to image focal infection in rats. J Nucl Med. 1995;36:1639–1644
  47. Oyen WJG, Boerman OC, Storm G, et al. Detecting infection and inflammation with technetium-99m-labeled Stealth liposomes. J Nucl Med. 1996;37:1392–1397
  48. Oyen WJG, Boerman OC, Dams ETM, et al. Scintigraphic evaluation of experimental colitis in rabbits. J Nucl Med. 1997;38:1596–1600
  49. Dams ETM, Oyen WJG, Boerman OC, et al. Tc-99m-labeled liposomes to image experimental colitis in rabbits: Comparison with Tc-99m-HMPAO-granulocytes and Tc-99m-HYNIC-IgG. J Nucl Med. 1998;39:2172–2178
  50. Dams ETM, Nijhof MW, Oyen WJG, et al. Scintigraphic evaluation of experimental chronic osteomyelitis. J Nucl Med. 2000;41:896–902
  51. Dams ETM, Oyen WJG, Boerman OC, et al. Tc-99m-FEG-liposomes for the scintigraphic detection of infection and inflammation: Clinical evaluation. J Nucl Med. 2000;41:622–630
  52. Brouwers AH, De Jong DJ, Dams ETM, et al. Tc-99m-PEG-liposomes for the evaluation of colitis in Crohn's disease. J Drug Targeting. 2000;8:225–233
  53. (abstr) Zoghbi S, Thakur M, Gottschalk A. Selective cell labeling: A potential radioactive agent for labeling of human neutrophils. J Nucl Med. 1981;22:32P
  54. McAfee JG, Subramanian G, Gagne G. Technique of leukocyte harvesting and labeling: Problems and perspectives. Semin Nucl Med. 1984;14:83–106
  55. Fischman AJ, Pike MC, Kroon D, et al. Imaging focal sites of bacterial infection in rats with indium-111-labeled chemotactic peptid analogs. J Nucl Med. 1991;32:483–491
  56. Babich JW, Graham W, Barrow SA, et al. Technetium-99m-labeled chemotactic peptides: Comparison with indium-111-labeled white blood cells for localizing acute bacterial infection in the rabbit. J Nucl Med. 1993;34:2176–2181
  57. Fischman AJ, Rauh D, Solomon H, et al. In vivo bioactivity and biodistribution of chemotactic peptide analogs in nonhuman primates. J Nucl Med. 1993;34:2130–2134
  58. Pollak A, Goodbody AE, Ballinger JR, et al. Imaging inflammation with Tc-99m labeled chemotactic peptides: Analogues with reduced neutropenial. Nucl Med Commun. 1996;17:132–139
  59. Babich JW, Dong Q, Graham W, et al. A novel high affinity chemotactic peptide antagonist for infection imaging. J Nucl Med. 1997;38:268P
  60. Chaudhuri MK, Konopinska D, Bump NJ, et al. The similarity between Tuftsin (Thr-Lys-Pro-Arg) receptors and Tuftsin antibody: A case of induced molecular mimicry. Ann N Y Acad Sci. 1983;419:135–142
  61. (abstr) Goodbody A, Ballinger J, Tran L, et al. A new Tc-99m labeled peptide inflammation imaging agent. Eur J Nucl Med. 1994;21:790
  62. Caveliers V, Goodbody AE, Tran LL, et al. Evaluation of 99mTc-RP128 as a potential inflammation imaging agent: Human dosimetry and first clinical results. J Nucl Med. 2001;42:154–161
  63. van der Laken CJ, Boerman OC, Oyen WJG, et al. Specific targeting of infectious foci with radioiodinated human recombinant interleukin-1 in an experimental model. Eur J Nucl Med. 1995;22:1249–1255
  64. van der Laken CJ, Boerman OC, Oyen WJG, et al. Preferential localization of systemically administered radiolabeled interleukin-1 a in experimental inflammation in mice by binding to the type II receptor. J Clin Invest. 1997;100:2970–2976
  65. van der Laken CJ, Boerman OC, Oyen WJG, et al. Imaging of infection in rabbits with radioiodinated interleukin-1 (α and β), its receptor antagonist and a chemotactic peptide: A comparative study. Eur J Nucl Med. 1998;25:347–352
  66. Barrera P, van der Laken CJ, Boerman OC, et al. Localization of 123I-IL-ra in affected joints in patients with rheumatic arthritis. Rheumatology. 2000;39:870–874
  67. Signore A, Chianelli M, Toscano A, et al. A radiopharmaceutical for imaging areas of lymphocytic infiltration, 123I-interleukin-2 labeling procedure and animal studies. Nucl Med Commun. 1992;13:713–722
  68. Chianelli M, Signore A, Fritzberg AR, et al. The development of technetium-99m-labeled interleukin-2: A new radiopharmaceutical for the in vivo detection of mononuclear cell infiltrates in immune-mediated diseases. Nucl Med Biol. 1997;24:579–586
  69. Signore A. Interleukin-2 scintigraphy: An overview. Nucl Med Commun. 1999;20:938
  70. Hay RV, Skinner RS, Newman OC, et al. Scintigraphy of acute inflammatory lesions in rats with radiolabeled recombinant human interleukin-8. Nucl Med Commun. 1997;18:367–378
  71. Gross MD, Shapiro B, Skinner RS, et al. Scintigraphy of osteomyelitis in man with human recombinant interleukin-8. J Nucl Med. 1996;37:25P
  72. van der Laken CJ, Boerman OC, Oyen WJG, et al. Radiolabeled interleukin-8: Scintigraphic detection of infection within a few hours. J Nucl Med. 2000;41:463–469
  73. Rennen HJJM, Boerman OC, Oyen WJG, et al. Specific and rapid scintigraphic detection of infection with Tc-99m-labeled interleukin-8. J Nucl Med. 2001;42:117–123
  74. Moyer BR, Vallabhajosula S, Lister-James J, et al. Technetium-99m-white blood cell-specific imaging agent developed from platelet factor 4 to detect infection. J Nucl Med. 1996;37:673–679
  75. Palestro CJ, Tomas MB, Bhargava KK, et al. Tc-99m P483H for imaging infection: Phase 2 multicenter trial results. J Nucl Med. 1999;40:15P
  76. Vinjamuri S, Hall AV, Solanki KK, et al. Comparison of 99mTc infection imaging with radiolabeled white-cell imaging in the evaluation of bacterial infection. Lancet. 1996;347:233–235
  77. Hall AV, Solanki KK. Evaluation of the efficacy of 99mTc-infection, a novel agent detecting sites of infection. J Clin Pathol. 1998;51:215–219
  78. Welling MM, Hiemstra PS, van den Barselaar MT, et al. Antibacterial activity of human neutrophil defensins in experimental infections in mice is accompanied by in-creased leukocyte accumulation. J Clin Invest. 1998;102:1583–1590
  79. Welling MM, Nibbering PH, Paulusma-Annema A, et al. Imaging of bacterial infections with 99mTc-labeled human neutrophil peptide-1. J Nucl Med. 1999;40:2073–2080
  80. Welling MM, Paulusma-Annema A, Balter HS, et al. Technetium-99m labeled antimicrobial peptides discriminate between bacterial infections and sterile inflammations. Eur J Nucl Med. 2000;27:292–301
  81. O'Doherty MJ. PET in oncology. I. Lung, breast, soft tissue sarcoma. Nucl Med Commun. 2000;21:224–229
  82. Nunan TO, Hain SF. PET in oncology. II. Other tumours. Nucl Med Commun. 2000;21:229–233
  83. Strauss LG. Fluorine-18 deoxyglucose and false-positive results: A major problem in the diagnostics of oncological patients. Eur J Nucl Med. 1996;23:1409–1415
  84. Tahara T, Ichiya Y, Kuwabara Y, et al. High [18F]-fluoro-deoxyglucose uptake in abdominal abscesses: A PET study. J Comput Assist Tomogr. 1989;13:829–831
  85. Ichiya Y, Kuwabara Y, Sasaki M, et al. FDG-PET in infectious lesions: The detection and assessment of lesion activity. Ann Nucl Med. 1996;10:185–191
  86. O'Doherty MJ, Barrington SF, Campbell M, et al. PET scanning and the human immunodeficiency virus-positive patient. J Nucl Med. 1997;38:1575–1583
  87. Guhlmann A, Brecht-Krauss D, Suger G, et al. Chronic osteomyelitis: Detection with FDG PET and correlation with histopathologic findings. Radiology. 1998;206:749–754
  88. Sugawara Y, Braun DK, Kison PV, et al. Rapid detection of human infections with fluorine-18 fluorodeoxyglucose and positron emission tomography: Preliminary results. Eur J Nucl Med. 1998;25:1238–1243
  89. Guhlmann A, Brecht-Krauss D, Suger G, et al. Fluorine-18-FDG PET and technetium-99m antigranulocyte antibody scintigraphy in chronic osteomyelitis. J Nucl Med. 1998;39:2145–2152
  90. Zhuang H, Duarte PS, Pourdehand M, et al. Exclusion of chronic osteomyelitis with F-18 fluorodeoxyglucose positron emission tomographic imaging. Clin Nucl Med. 2000;25:281–284
  91. Kalicke T, Schmitz A, Risse JH, et al. Fluorine-18 fluorodeoxyglucose PET in infectious bone diseases: Results of histologically confirmed cases. Eur J Nucl Med. 2000;27:524–528
  92. Stumpe KD, Dazzi H, Schaffner A, et al. Infection imaging using whole-body FDG-PET. Eur J Nucl Med. 2000;27:822–832
  93. Zhuang H, Duarte PS, Pourdehnad M, et al. The promising role of 18F-FDG PET in detecting infected lower limb prosthesis implants. J Nucl Med. 2001;42:44–47

PII: S0001-2998(01)80008-8

doi: 10.1053/snuc.2001.26189

Seminars in Nuclear Medicine
Volume 31, Issue 4 , Pages 286-295 , October 2001

Article Tools